To our knowledge, there have so far been few studies of the role of TRPM2 channels in liver cells in the initiation of liver steatosis and in the progression non-alcoholic fatty liver disease to cirrhosis and hepatocellular carcinoma. The gene discussed is TRPM2; the disease is metabolic dysfunction-associated steatotic liver disease.